Common cold syndrome is a very frequent upper respiratory tract infection especially in childhood and can be caused by a variety of different respiratory virus such as rhinovirus, influenza virus, respiratory syncytial virus, adenovirus, metapneumovirus, parainfluenza virus, bocavirus, coronavirus and enterovirus ([@B27]). Despite being regarded as harmless diseases, they can cause significant morbidity and are the most common acute reason for children to visit their primary care physician\'s office ([@B2], [@B29]). It is well known that antibiotics are ineffective against viral infections and that inappropriate use can put patients at harm for allergic reactions and antibiotic-resistant infections ([@B19]. Although decreasing, recent studies have shown high rates of antibiotic prescription for viral respiratory infections, ranging from 20-60% ([@B16], [@B2]. Secondary bacterial infections such as sinusitis, acute otitis media (AOM) and even pneumonia can occur after common cold episodes, but most cases of common colds follow a self-limited predictable course and recognising its usual signs and symptoms could avoid unnecessary antibiotic therapy (Dowell et al. 1998b). To combat the spread of resistant bacteria, judicious prescription of antibiotics has become an important target of medical organisations worldwide ([@B8], [@B21]. In order to describe the viral aetiology of common colds and to best address the problem of antibiotic prescription for these viral respiratory infections in children, we conducted an observational study at an outpatient primary care facility in Brazil.

PATIENTS, MATERIALS AND METHODS
===============================

The study was conducted from 1 March 2008-28 February 2009 at a primary care facility in São Paulo, Southeast Region of Brazil. Children of less than 12 years of age were attended by paediatricians and the clinical diagnosis was coded using the International Classification of Disease, 10th Revision. All children seen on Tuesday\'s and Friday\'s mornings with the diagnosis of common cold (J00) or acute upper respiratory infections of multiple and unspecified sites (J06) with symptoms starting in the last five days were included in the study sample. Patients with any associated codes for sinusitis, otitis media, bacterial pharyngitis, pneumonia or who had underlying chronic heart or lung disease or any other chronic health problem or immune disorder were excluded. Patients who had used antibiotics in the last five days were also excluded. The study was approved by the Ethical Committee of São Paulo Federal University (CEP 0670/08) and written informed consent was obtained from parents or guardians before enrollment of each patient.

An independent paediatrician who was not responsible for any clinical intervention filled out a standardised case report form that included information on demographic characteristics and clinical syndrome for each enrolled patient. Data of follow-up were obtained in medical records of subsequent office visits and also by regular telephone calls to the parents every two or three days. All data were entered on the form until the resolution of the respiratory illness. Data about medical prescription of antibiotics, symptoms on the day of antibiotic prescription, laboratory tests and X-ray exams reports were recorded on the form. The use of antibiotics was considered appropriate for all patients with signs and symptoms of secondary bacterial infection diagnosed as AOM, bacterial sinusitis or pneumonia with evidence of parenchymal infiltrates in the chest X-ray exam. For patients with the diagnosis of sinusitis, the use of antibiotics was considered appropriate in cases of symptoms of rhinosinusitis and cough without improvement for more than 10-14 days or more severe upper respiratory tract signs and symptoms, i.e., fever ≥ 39ºC, facial swelling, facial pain (Dowell et al. 1998a).

*Laboratory tests* - A sample of nasopharyngeal wash was obtained from each patient at the enrollment visit. The median time from the onset of symptoms to the collection of nasal washings was three days (1-5 days). Samples were collected and processed using previously published procedures ([@B11]) and immediately transported to the laboratory for respiratory virus testing.

Respiratory samples were tested first with the commercial panel SimulFluor Respiratory Screen (Chemicon International, USA) for detection of seven respiratory viruses: respiratory syncytial virus, influenza A and B viruses, parainfluenza virus types 1-3 and adenovirus, as described previously ([@B6], [@B11]). Original specimens were then stored at -80°C for further analysis and as polymerase chain reaction (PCR) tests became available in our laboratory, the viral RNA and DNA were extracted from each sample using QIAamp Viral RNA and DNA extraction Kit (Qiagen, USA) according to the manufacturer\'s instructions. Nucleic acid extracts were tested by PCR for the detection of respiratory syncytial virus, influenza A and B viruses, adenovirus, rhinovirus, metapneumovirus, bocavirus, coronavirus and enterovirus, according to published methods ([@B4], [@B28], [@B17],[@B18], [@B3], [@B9], [@B31], [@B12]).

*Statistical analysis* - Statistical analysis was performed using SPSS 20.0 and Stata 12 statistical softwares and the statistical significance level for all tests was 5%. The existence of associations between two categorical variables was verified using the chi-square test or the Fisher\'s exact test depending on the sample size. The Student\'s *t* test was used to perform comparisons of averages between two groups of data in cases of independent samples. To compare more than two averages, the analysis of variances (ANOVA) was used. Normal distribution of data was previously verified using Kolmogorov-Smirnov test. Nonparametric Mann-Whitney *U* and Kruskal-Wallis tests were used to compare the averages of samples that did not meet the normality assumption. If differences were found between averages, multiple comparisons were performed to localise such differences. For the pairwise comparisons of groups, adjustments in the descriptive levels were made so that the overall significance was 5%.

RESULTS
=======

During the whole study, 3,282 medical consultations were carried out, 29% (955/3282) of which were coded as common cold or acute upper respiratory infections of multiple and unspecified sites. Of these 955 common cold cases, a sample of 134 patients who met the inclusion criteria was obtained, median age 2.9 years (0.1-11.2 y), 49% male. The most frequent symptoms were coryza (91.8%, 123/134), cough (90.3%, 121/134), fever (56%, 75/134) and wheezing (46.3%, 62/134). Respiratory viruses were detected in 73.9% (99/134) of nasopharyngeal wash samples (1 sample per patient) with a coinfection rate of 30.3% (30/99). The laboratory tests findings are described in [Table I](#t1){ref-type="table"}.

TABLE IDescription of the respiratory virus findings in 134 cases of children with common colds, São Paulo, Brazil, 2008-2009VirusPositive samples^*a*^ n (%)Rhinovirus30 (22.4)Respiratory syncytial virus12 (9)Influenza A12 (9)Influenza B6 (4.5)Adenovirus6 (4.5)Enterovirus2 (1.5)Metapneumovirus1 (0.7)Total of monoinfection cases69 (51.5)Rhinovirus and influenza A6 (4.5)Rhinovirus and adenovirus4 (3)Rhinovirus and respiratory syncytial virus3 (2.2)Adenovirus and influenza A3 (2.2)Rhinovirus and influenza B2 (1.5)Rhinovirus and bocavirus2 (1.5)Influenza B and coronavirus2 (1.5)Rhinovirus and enterovirus1 (0.7)Rhinovirus and coronavirus1 (0.7)Respiratory syncytial virus and enterovirus1 (0.7)Respiratory syncytial virus and coronavirus1 (0.7)Total of coinfection cases with 2 viruses26 (19.4)Rhinovirus, influenza A and enterovirus1 (0.7)Rhinovirus, influenza A and bocavirus1 (0.7)Rhinovirus, respiratory syncytial virus and adenovirus1 (0.7)Rhinovirus, coronavirus and metapneumovirus1 (0.7)Total of coinfection with 3 viruses4 (3)Total positive99 (73.9)Total negative35 (26.1)Total134 (100)[^1]

Overall, the antibiotic prescription rate was 39.6% (53/134), among which 60.4% (32/53) was amoxicillin, 22.6% (12/53) macrolides, 9.4% (5/53) cephalosporins and 7.6% (4/53) amoxicillin plus sulbactam ([Table II](#t2){ref-type="table"}). Of 53 patients who received antibiotics during the follow-up, only 30.2% (16/53) received them judiciously and the other 69.8% (37/53) received them inappropriately. Among these 37 cases with inappropriate use, the clinical justifications for prescription of antibiotics were: in 37.7% (20/53) to treat nasal or postnasal discharge during the first week of common cold symptoms in patients without fever, in 18.9% (10/53) to treat persistence of cough during the first week of symptoms, in 11.3% (6/53) to treat common cold and in 1.9% (1/53) to treat wheezing symptom.

TABLE IILaboratory findings and prescription of antibiotics during the follow-up of children with common colds Age (years)VirusAntibioticDay of antibiotic introduction^*a*^Judicious prescription    Sinusitis0.5RVAZI91.7RVAMO141.8RVAMO183RV/IFA/AdVAMO103NEGAMO195.6RVAMO47.1RV/IFBCCL5Acute otitis media0.4RSVAMO120.5RV/IFAAMO40.6RV/BoVAMO50.7NEGAMO31.1RSVAMO54.8NEGAZI8Pneumonia0.6NEGAMO100.7RVCLAR120.9NEGAMO + SB4Inappropriate prescriptionCommon cold6.2RVAMO10.7IFBAMO12.2IFAAMO20.6IFBERY32.1IFAAMO + SB3Nasal /postnasal secretion7.8NEGAMO24.3IFBCEX35.3RVAMO32RSVAMO32RSVAMO35.5NEGAZI33.9RV/IFAAZI38.7IFA/AdVCEX40.5RSV/RVAMO44.1RV/IFAAZI46.6IFAAMO43.2RV/BoV/IFAAMO48.1IFBAMO56.7RV/CovAMO56.7RV/IFAAMO58.8IFAAZI56.5RSVAMO511.2NEGAMO6Cough1.1RV/EV/IFAAMO27.2NEGAZI29.7NEGCEX20.4NEGCLAR20.5RSV/AdV/RVAMO37.3NEGCEX30.7NEGAMO30.5RVAMO33.8NEGAMO + SB43.8IFAAMO + SB51.1IFAAMO60.2RSV/RVAMO7Wheezing0.8RVAMO2Pharyngitis2.9IFB/CovAMO6[^2]

Among 75 children who had fever at the onset of symptoms, 45.3% (34/75) were prescribed antibiotics whereas 32.2% (19/59) of those who did not have fever at the onset of symptoms received antibiotics. Thus, there was no difference in the proportion of antibiotic prescriptions between children who had fever at the onset of symptoms and those who did not (p = 0.123).

Of a total of 53 children who received antibiotics, 34 presented fever at onset of symptoms and of these, 29.4% (10/34) received judicious prescription of antibiotics. Of the remaining 19 children who did not have fever at the onset of common cold symptoms and received antibiotics, 31.6% (6/19) were prescribed antibiotics judiciously. Thus, there was also no difference for judicious prescription of antibiotics between children with fever and those without fever at the onset of common cold symptoms (p = 0.869).

The average time to the resolution of symptoms of children with signs of secondary bacterial infection was of 16.7 days and, within this group, all children received antibiotics. Among children with no signs of bacterial infection, the average time to the resolution of symptoms was 8.9 days for the group that received antibiotics and 7.0 days for the group that did not.

Among patients with respiratory virus monoinfection, all patients with influenza received antibiotics inappropriately (10/10), whereas those with respiratory syncytial virus were prescribed antibiotics inappropriately in 60% (3/5) and those with rhinovirus were prescribed antibiotics inappropriately in 44.4% of cases (5/9) (p = 0.016). Also, of seven patients coinfected with influenza, 71.4% (5/7) received antibiotics inappropriately, as showed in [Table II](#t2){ref-type="table"}. None of the patients were vaccinated against influenza by the time of the study.

DISCUSSION
==========

Inappropriate use of antibiotics for viral common colds is an important problem worldwide but, until now, we did not have clinical studies addressing this problem in Brazil. During the clinical course of a common cold, secondary bacterial infections may occur, however, antimicrobials are frequently used inappropriately for events that are normal during the clinical course of a viral infection (Dowell et al. 1998b). In our study, this practice was particularly evident in cases of viral rhinosinusitis, since 37.7% (20/53) of patients received antibiotics for the presence of nasal or postnasal discharge during the first week of common cold symptoms without fever. During childhood, 20-40% of common colds can be complicated by AOM ([@B32], [@B13]) and although current recommendations on management of AOM encourage the initial observation of nonsevere AOM cases in selected children (i.e., "watchful waiting") ([@B1]), there are still controversies around the diagnosis and management of AOM ([@B22],[@B30]). In routine practice, the over diagnosis of AOM is frequent but, considering that there are difficulties in confirming the diagnosis, in our study we considered all indications of antibiotic for AOM as adequate regardless of the patients\' age, severity of symptoms and certainty of diagnosis. We believe that rates of inappropriate use of antibiotics could be even greater if stringent diagnostic criteria were applied for AOM diagnosis.

Amoxicillin was the first choice for antibiotic therapy accounting for 60.4% (32/53) of all prescriptions but, on the other hand, the second most prescribed antibiotics were macrolides (22.6%, 12/53) which is not in accordance with current guidelines ([@B7]). Predominantly in the paediatric outpatient population, the growing emergence of bacterial resistance to macrolides is related to delayed cure and is responsible for a great proportion of costs currently associated with antibiotic resistant pneumococcal infections ([@B24], [@B26]). Continuing medical education programs aimed not only to reduce the inappropriate use of antibiotics, but also to teach the best practices of antibiotic therapy could be of great help to improve this scenario.

Diagnostic uncertainty, which is defined as the difficulty in distinguishing a self-limited viral infection from a bacterial infection requiring antibiotic therapy is identified by researchers as a factor that contributes for antibiotic overuse ([@B5]). Thus, the difficulty in predicting a bacterial infection in febrile children could lead to the misuse of antibiotics. Bacterial infections are associated with worsening of clinical conditions with a consequent longer time for the resolution of symptoms. However, common colds without secondary infections follow a self-limited course of seven-10 days with no reduction of the duration of symptoms with the use of antibiotic, as it was observed in this study and as reported elsewhere in the medical literature ([@B23], [@B8], [@B25], [@B10]).

Although our study was not designed to evaluate the influence of fever in medical decision to prescribe antibiotics, we observed that there was no difference in the proportion of antibiotic prescriptions for patients who had fever at the onset of symptoms and for those who did not, as well as in the proportion of judicious prescription of antibiotics for these two groups of patients. Additional research is needed to identify the local factors that are determinants of antibiotic misuse.

Although it is well known that influenza vaccination is the primary strategy to prevent influenza, the Brazilian Health Ministry started public vaccination campaigns against influenza for children in 2010 so that part of the population had no access to influenza vaccine by the time of the study. None of the patients of the study were vaccinated against influenza and this fact could explain the high frequency of influenza infection in our patients (23.1%; 31/134), as showed in [Table I](#t1){ref-type="table"}.

Antiviral treatment also plays an important role in decreasing influenza-related morbidity and mortality, but none of 33 patients with laboratory confirmed influenza infection received antiviral therapy, whereas all patients with influenza monoinfection received antibiotics inappropriately (10/10) and those coinfected with influenza and other viruses also received antibiotics inappropriately in a great proportion of cases (71.4%; 5/7). A recent study in the United States of America reported that during 2012-2013, antiviral medications were underprescribed and antibiotics may have been inappropriately prescribed to a large proportion of outpatients with influenza ([@B20]). The referred study emphasises that the use of sensitive and specific tests for the rapid diagnosis of influenza and other respiratory viruses is strongly recommended and could decrease antibiotic use and guide appropriate use of antiviral agents in both outpatient and inpatient settings ([@B7]). In Brazil, diagnostic tests for respiratory virus are still expensive and are not easily available for the vast majority of the population, especially for low income people.

This study was conducted at one primary care facility and it is not possible to generalise the results to all Brazilian primary health care services, however, these preliminary data will help us to better understand antibiotic misuse among children with common cold viral infections. We believe that continuing education on appropriate antibiotics and antivirals use as well as accessibility to influenza vaccination, sensitive and specific tests for the rapid diagnosis of respiratory viruses and antiviral medication are essential to improve primary healthcare quality.

To the UNIFESP Clinical Virology Laboratory staff members, for the execution of laboratory tests.

[^1]: *a*: numbers of positive samples are a combination of positive direct fluorescence, polymerase chain reaction (PCR) and reverse transcription-PCR results.

[^2]: *a*: day 1 was the first day of common cold symptoms; AdV: adenovirus; AMO: amoxicillin; AZI: azithromycin; BoV: bocavirus; CCL: cefaclor; CEX: cephalexin; CLAR: clarithromycin; Cov: coronavirus; ERY: erythromycin; EV: enterovirus; IFA: influenza A; IFB: influenza B; NEG: negative; RSV: respiratory syncytial virus; RV: rhinovirus; SB: sulbactam.
